HonCode

Go Back   HER2 Support Group Forums > Breast Cancer Newsfeed
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 07-08-2013, 03:30 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,104
Patients With Advanced Breast Cancer Denied Routine Access To Breakthrough Treatment,

Novartis today expressed great disappointment that the National Institute for Health and Care Excellence (NICE) has issued a final decision not to recommend its innovative advanced breast cancer treatment, Afinitor® (everolimus), to be available to patients on the NHS...

More...
News is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 12:11 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter